Around the Net

Biotech Company Amgen Nearing Purchase Of Horizon Therapeutics

In what will probably "mark the largest healthcare merger of the year," biotech company Amgen Inc. is in advanced talks to buy pharma company Horizon Therapeutics PLC. Amgen "was the last of three suitors standing in an auction for Horizon," according to The Wall Street Journal. Horizon "develops medicines to treat rare autoimmune and severe inflammatory diseases."

Read the whole story at The Wall Street Journal »

Next story loading loading..